Table 10.6b

Immunosuppression Use for Induction by Discharge Regimen, 2002 to 2006

Recipients with Intestine Transplants

  Discharge Regimen (w/ or w/o Steroids Use) All
CyA Tac Tac+ MMF Tac+ Aza Tac+ Siro Other
Functioning Graft with Immunosuppression Info at Discharge 1 458 67 1 63 27 617
% of All Regimens 0.2% 74.2% 10.9% 0.2% 10.2% 4.4% 100.0%
Induction Drug 0.0% 0.2% 6.0% 0.0% 1.6% 18.5% 1.8%
Atgam/NRATG/NRATS
OKT3 0.0% 3.3% 16.4% 0.0% 4.8% 25.9% 5.8%
Thymoglobulin 0.0% 19.4% 38.8% 0.0% 31.7% 125.9% 27.4%
Zenapax 0.0% 11.8% 38.8% 0.0% 6.3% 74.1% 16.9%
Simulect 0.0% 2.2% 0.0% 0.0% 20.6% 14.8% 4.4%
Campath 0.0% 21.6% 4.5% 0.0% 1.6% 40.7% 18.5%
No Induction Drugs Recorded 100.0% 44.8% 16.4% 100.0% 39.7% 40.7% 41.2%


Source: OPTN/SRTR Data as of May 1, 2007.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.

CyA: Cyclosporine; Tac: Tacrolimus; MMF: Include MMF(Mycophenolate Mofetil) and MPA(Mycophenolate Sodium); Aza: Azathioprine; Siro: Sirolimus.